Publicacions (50) Publicacions de IGNACIO JESÚS MOLINA PINEDA INFANTAS

2024

  1. A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical Analysis

    Journal of Molecular Diagnostics, Vol. 26, Núm. 1, pp. 17-28

2023

  1. COVID-19: Inmunopatología, diagnóstico, clínica y tratamiento

    Manual de neumología para médicos en formación (Avicam), pp. 309-342

  2. Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2022

  1. (-)-Oleocanthal induces death preferentially in tumor hematopoietic cells through caspase dependent and independent mechanisms

    Food & function, Vol. 13, Núm. 21, pp. 11334-11341

  2. First international workshop of the ATM and cancer risk group (4-5 December 2019)

    Familial Cancer, Vol. 21, Núm. 2, pp. 211-227

2021

  1. Novel purine chemotypes with activity against plasmodium falciparum and trypanosoma cruzi

    Pharmaceuticals, Vol. 14, Núm. 7

  2. Synthesis and screening of 6-alkoxy purine analogs as cell type-selective apoptotic inducers in Jurkat cells

    Archiv der Pharmazie, Vol. 354, Núm. 10

2020

  1. Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 8, pp. 2793-2795

2018

  1. 1H and 13C assignments of 6-, 8-, 9- substituted purines

    Magnetic Resonance in Chemistry

  2. Reconstitution of the ataxia-telangiectasia cellular phenotype with lentiviral vectors

    Frontiers in Immunology, Vol. 9, Núm. NOV

2017

  1. Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia

    NeuroMolecular Medicine, Vol. 19, Núm. 1, pp. 161-174

2015

  1. Regulated expression of murine CD40L by a lentiviral vector transcriptionally targeted through its endogenous promoter

    Journal of Gene Medicine, Vol. 17, Núm. 10-12, pp. 219-228

  2. Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors

    Organic and Biomolecular Chemistry, Vol. 13, Núm. 18, pp. 5224-5234

2013

  1. IL-17 producing t cells in celiac disease: Angels or devils

    International Reviews of Immunology, Vol. 32, Núm. 5-6, pp. 534-543

  2. X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivation

    Blood Cells, Molecules, and Diseases, Vol. 51, Núm. 2, pp. 125-129

2012

  1. Biomedical Applications of Exopolysaccharides Produced by Microorganisms Isolated from Extreme Environments

    Extremophiles: Sustainable Resources and Biotechnological Implications (John Wiley and Sons), pp. 357-366

  2. El Parque Tecnológico de Ciencias de la Salud y su papel en la investigación biomédica de Andalucía

    Andalucía Económica, Núm. 246, pp. 33

2011

  1. A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences

    Gene Therapy, Vol. 18, Núm. 4, pp. 364-371

  2. An exopolysaccharide produced by the novel halophilic bacterium Halomonas stenophila strain B100 selectively induces apoptosis in human T leukaemia cells

    Applied Microbiology and Biotechnology, Vol. 89, Núm. 2, pp. 345-355

  3. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients

    American Journal of Gastroenterology, Vol. 106, Núm. 3, pp. 528-538